Literature DB >> 26876401

Dual Diagnosis and Suicide Probability in Poly-Drug Users.

Ismail M Youssef1, Magda T Fahmy1, Wafaa L Haggag1, Khalid A Mohamed1, Amany A Baalash2.   

Abstract

OBJECTIVE: To determine the frequency of suicidal thoughts and suicidal probability among poly-substance abusers in Saudi population, and to examine the relation between dual diagnosis and suicidal thoughts. STUDY
DESIGN: Case control study. PLACE AND DURATION OF STUDY: Al-Baha Psychiatric Hospital, Saudi Arabia, from May 2011 to June 2012.
METHODOLOGY: Participants were 239 subjects, aged 18 - 45 years. We reviewed 122 individuals who fulfilled the DSM-IV-TR criteria of substance abuse for two or more substances, and their data were compared with that collected from 117 control persons.
RESULTS: Suicidal cases were highly present among poly-substance abusers 64.75%. Amphetamine and cannabis were the most abused substances, (87.7% and 70.49%, respectively). Astatistically significant association with suicidality was found with longer duration of substance abuse (p < 0.001), using alcohol (p=0.001), amphetamine (p=0.007), volatile substances (p=0.034), presence of comorbid psychiatric disorders (dual diagnosis) as substance induced mood disorder (p=0.001), schizo-affective disorder (p=0.017), major depressive disorders (p=0.001), antisocial (p=0.016) and borderline (p=0.005) personality disorder. Suicidal cases showed significant higher scores (p < 0.001) of suicide probability scale and higher scores in Beck depressive inventory (p < 0.001).
CONCLUSION: Abusing certain substances for long duration, in addition to comorbid psychiatric disorders especially with disturbed-mood element, may trigger suicidal thoughts in poly-substance abusers. Depression and suicide probability is common consequences of substance abuse.

Entities:  

Mesh:

Year:  2016        PMID: 26876401     DOI: 02.2016/JCPSP.130133

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.

Authors:  Tessa Frohe; Cheryl L Beseler; Andres M Mendoza; Linda B Cottler; Robert F Leeman
Journal:  J Consult Clin Psychol       Date:  2019-10

Review 2.  Substance use disorders in Saudi Arabia: a scoping review.

Authors:  Nazmus Saquib; Ahmad Mamoun Rajab; Juliann Saquib; AbdulRahman AlMazrou
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-06-17

3.  Attitudes and Associated Demographic Factors Contributing towards the Abuse of Illicit Drugs: A Cross-Sectional Study from Health Care Students in Saudi Arabia.

Authors:  Wajid Syed; Ayesha Iqbal; Nasir A Siddiqui; Ramzi A Mothana; Omer Noman
Journal:  Medicina (Kaunas)       Date:  2022-02-21       Impact factor: 2.430

4.  The role of psychiatric symptoms and environmental vulnerability factors in explaining the relationship between child maltreatment and suicidality: A prospective investigation.

Authors:  Cathy Spatz Widom; Xuechen Li
Journal:  J Affect Disord       Date:  2020-07-14       Impact factor: 6.533

5.  The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia.

Authors:  Reece Cossar; Mark Stoové; Stuart A Kinner; Paul Dietze; Campbell Aitken; Michael Curtis; Amy Kirwan; James R P Ogloff
Journal:  Health Justice       Date:  2018-01-13

6.  Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis.

Authors:  Rebecca McKetin; Janni Leung; Emily Stockings; Yan Huo; James Foulds; Julia M Lappin; Craig Cumming; Shalini Arunogiri; Jesse T Young; Grant Sara; Michael Farrell; Louisa Degenhardt
Journal:  EClinicalMedicine       Date:  2019-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.